Vangl1 Protein Acts as a Downstream Effector of Intestinal Trefoil Factor (ITF)/TFF3 Signaling and Regulates Wound Healing of Intestinal Epithelium von Kalabis, Jiri, Rosenberg, Ian, Podolsky, Daniel K.

Volltext

Reciprocal regulation of MelCAM and AKT in human melanoma von Li, Gang, Kalabis, Jiri, Xu, Xiaowei, Meier, Friedegund, Oka, Masahiro, Bogenrieder, Thomas, Herlyn, Meenhard

Volltext

Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen‐embedded fibroblasts in organotypic culture von Kalabis, Jiri, Patterson, Michael J., Enders, Greg H., Marian, Brigitte, Iozzo, Renato V., Rogler, Gerhard, Gimotty, Phyllis A., Herlyn, Meenhard

Volltext

Biomarkers for predicting response to regional chemo-immunotherapy in liver metastases from colorectal carcinoma von ZALOUDIK, J, VAGUNDA, V, DRAHOKOUPILOVA, M, JANAKOVA, L, TALAC, R, KALABIS, J, SHEARD, M

Volltext

Biomarkers for predicting response to regional chemoimmunotherapy in liver metastases from colorectal carcinoma von Zaloudik, J., Vagunda, V., Drahokoupilova, M., Janakova, L., Talac, R., Kalabis, J., Sheard, M.

Volltext

Biological factors predicting the outcome of regional chemotherapy in colorectal carcinoma metastases to liver von Zaloudik, J., Vagunda, V., Drahokoupilová, M., Janáková, L., Kalabis, J., Nekulová, M., Vojtešek, B., Kocák, I., Karásek, P.

Volltext

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance von Somasundaram, Rajasekharan, Zhang, Gao, Fukunaga-Kalabis, Mizuho, Perego, Michela, Krepler, Clemens, Xu, Xiaowei, Wagner, Christine, Hristova, Denitsa, Zhang, Jie, Tian, Tian, Wei, Zhi, Liu, Qin, Garg, Kanika, Griss, Johannes, Hards, Rufus, Maurer, Margarita, Hafner, Christine, Mayerhöfer, Marius, Karanikas, Georgios, Jalili, Ahmad, Bauer-Pohl, Verena, Weihsengruber, Felix, Rappersberger, Klemens, Koller, Josef, Lang, Roland, Hudgens, Courtney, Chen, Guo, Tetzlaff, Michael, Wu, Lawrence, Frederick, Dennie Tompers, Scolyer, Richard A., Long, Georgina V., Damle, Manashree, Ellingsworth, Courtney, Grinman, Leon, Choi, Harry, Gavin, Brian J., Dunagin, Margaret, Raj, Arjun, Scholler, Nathalie, Gross, Laura, Beqiri, Marilda, Bennett, Keiryn, Watson, Ian, Schaider, Helmut, Davies, Michael A., Wargo, Jennifer, Czerniecki, Brian J., Schuchter, Lynn, Herlyn, Dorothee, Flaherty, Keith, Herlyn, Meenhard, Wagner, Stephan N.

Volltext

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, rando... von Long, Georgina V, Luke, Jason J, Khattak, Muhammad A, de la Cruz Merino, Luis, Del Vecchio, Michele, Rutkowski, Piotr, Spagnolo, Francesco, Mackiewicz, Jacek, Chiarion-Sileni, Vanna, Kirkwood, John M, Robert, Caroline, Grob, Jean-Jacques, de Galitiis, Federica, Schadendorf, Dirk, Carlino, Matteo S, Mohr, Peter, Dummer, Reinhard, Gershenwald, Jeffrey E, Yoon, Charles H, Wu, Xi Lawrence, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Eggermont, Alexander M M, Ascierto, Paolo A

Volltext

Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma von Long, Georgina V, Luke, Jason J, Fukunaga-Kalabis, Mizuho, Ascierto, Paolo A

Volltext

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma von Nghiem, Paul, Bhatia, Shailender, Lipson, Evan J, Sharfman, William H, Kudchadkar, Ragini R, Brohl, Andrew S, Friedlander, Philip A, Daud, Adil, Kluger, Harriet M, Reddy, Sunil A, Boulmay, Brian C, Riker, Adam, Burgess, Melissa A, Hanks, Brent A, Olencki, Thomas, Kendra, Kari, Church, Candice, Akaike, Tomoko, Ramchurren, Nirasha, Shinohara, Michi M, Salim, Bob, Taube, Janis M, Jensen, Erin, Kalabis, Mizuho, Fling, Steven P, Homet Moreno, Blanca, Sharon, Elad, Cheever, Martin A, Topalian, Suzanne L

Volltext

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy von Somasundaram, Rajasekharan, Connelly, Thomas, Choi, Robin, Choi, Hyeree, Samarkina, Anastasia, Li, Ling, Gregorio, Elizabeth, Chen, Yeqing, Thakur, Rohit, Abdel-Mohsen, Mohamed, Beqiri, Marilda, Kiernan, Meaghan, Perego, Michela, Wang, Fang, Xiao, Min, Brafford, Patricia, Yang, Xue, Xu, Xiaowei, Secreto, Anthony, Danet-Desnoyers, Gwenn, Traum, Daniel, Kaestner, Klaus H., Huang, Alexander C., Hristova, Denitsa, Wang, Joshua, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Ping-Chen, Fang, Zhou, Xiangyang, Gutierrez, Alexis, Rebecca, Vito W., Vonteddu, Prashanthi, Dotiwala, Farokh, Bala, Shashi, Majumdar, Sonali, Dweep, Harsh, Wickramasinghe, Jayamanna, Kossenkov, Andrew V., Reyes-Arbujas, Jorge, Santiago, Kenisha, Nguyen, Tran, Griss, Johannes, Keeney, Frederick, Hayden, James, Gavin, Brian J., Weiner, David, Montaner, Luis J., Liu, Qin, Peiffer, Lukas, Becker, Jürgen, Burton, Elizabeth M., Davies, Michael A., Tetzlaff, Michael T., Muthumani, Kar, Wargo, Jennifer A., Gabrilovich, Dmitry, Herlyn, Meenhard

Volltext

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors von OHASHI, Shinya, NATSUIZAKA, Mitsuteru, KLEIN-SZANTO, Andres J, HERLYN, Meenhard, DIEHL, J. Alan, RUSTG, Anil K, NAKAGAWA, Hiroshi, WONG, Gabrielle S, MICHAYLIRA, Carmen Z, GRUGAN, Katharine D, STAIRS, Douglas B, KALABIS, Jiri, VEGA, Maria E, KALMAN, Ross A, NAKAGAWA, Momo

Volltext

53808 Adjuvant Pembrolizumab Versus Placebo in Stage IIB or IIC Melanoma: Exploratory Post Hoc Analyses of Patients with New Primary Melanoma and Other Skin Cancers from the Phase... von Leachman, Sancy, Luke, Jason J., Ascierto, Paolo, Long, Georgina V., Khattak, Muhammad A., Rutkowski, Piotr, Xu, Zhi Jin, Fukunaga-Kalabis, Mizuho, Krepler, Clemens

Volltext

Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma – Authors' reply von Long, Georgina V, Luke, Jason J, Fukunaga-Kalabis, Mizuho, Ascierto, Paolo A

Volltext

Downregulation of CCN3 expression as a potential mechanism for melanoma progression von Fukunaga-Kalabis, M, Martinez, G, Telson, S M, Liu, Z-J, Balint, K, Juhasz, I, Elder, D E, Perbal, B, Herlyn, M

Volltext

1078MO Pembrolizumab (pembro) vs placebo as adjuvant therapy for high-risk stage II melanoma: Long-term follow-up, rechallenge, and crossover in KEYNOTE-716 von Luke, J.J., Ascierto, P.A., Khattak, M.A., Rutkowski, P., Del Vecchio, M., Spagnolo, F., Mackiewicz, J., Cruz Merino, L. de la, Chiarion Sileni, V., Kirkwood, J.M., Robert, C., Schadendorf, D., De Galitiis, F., Carlino, M.S., Odeleye-Ajakaye, A., Kalabis, M., Krepler, C., Eggermont, A.M.M., Long, G.V.

Volltext

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study von Luke, Jason J, Ascierto, Paolo A, Khattak, Muhammad A, De La Cruz Merino, Luis, Del Vecchio, Michele, Rutkowski, Piotr, Spagnolo, Francesco, Mackiewicz, Jacek, Chiarion-Sileni, Vanna, Kirkwood, John M, Robert, Caroline, Grob, Jean Jacques, De Galitiis, Federica, Schadendorf, Dirk, Carlino, Matteo S, Wu, Xi Lawrence, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Center München, Munich, Germany, Comprehensive, Long, Georgina V

Volltext

Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene von Stairs, Douglas B., Bayne, Lauren J., Rhoades, Ben, Vega, Maria E., Waldron, Todd J., Kalabis, Jiri, Klein-Szanto, Andres, Lee, Ju-Seog, Katz, Jonathan P., Diehl, J. Alan, Reynolds, Albert B., Vonderheide, Robert H., Rustgi, Anil K.

Volltext

Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study von Luke, Jason J., Ascierto, Paolo Antonio, Khattak, Muhammad Adnan, de la Cruz Merino, Luis, Del Vecchio, Michele, Rutkowski, Piotr, Spagnolo, Francesco, Mackiewicz, Jacek, Chiarion-Sileni, Vanna, Kirkwood, John M. M., Robert, Caroline, Grob, Jean-Jacques, de Galitiis, Federica, Schadendorf, Dirk, Carlino, Matteo S., Wu, Larry, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Eggermont, Alexander M., Long, Georgina V.

Volltext

Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study von Khattak, Muhammad A., Luke, Jason J., Long, Georgina V., Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Robert, Caroline, Grob, Jean-Jacques, de la Cruz Merino, Luis, Del Vecchio, Michele, Spagnolo, Francesco, Mackiewicz, Jacek, Chiarion-Sileni, Vanna, Carlino, Matteo S., Mohr, Peter, De Galitiis, Federica, Ross, Merrick I., Eroglu, Zeynep, Chen, Ke, Jiang, Ruixuan, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Eggermont, Alexander M.M., Kirkwood, John M.

Volltext